Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment
Agreement includes further product development activities for Clinigen Limited
Lamda spurs further growth for Adragos as its 3rd site in Europe, and 5th globally
Munich / London / Athens, March 20th, 2023 - Munich-based pharmaceutical contract development organization (CDMO) Adragos Pharma GmbH has signed a definitive agreement with global pharmaceutical services company Clinigen Limited to acquire Lamda Laboratories S.